Association of CVD candidate gene polymorphisms with ischemic stroke and cerebral hemorrhage in Chinese individuals

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Ou, Wenjing ^a   Liu, Xin ^c   Shen, Yue ^c   Li, Jiana ^a   He, Lingbin ^b   Yuan, Yuan ^b   Tan, Xuerui ^b   Liu, Lisheng ^c   Zhao, Jingbo ^a   Wang, Xingyu ^b,c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^c Laboratory of Human Genetics Beijing Hypertension League Institute ^*  (China)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ADULT; ANP GENE; ARTICLE; BODY MASS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CHINESE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GENE; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MTHFR GENE; SYSTOLIC BLOOD PRESSURE; AGED; CASE CONTROL STUDY; CEREBRAL HEMORRHAGE; CHINA; COMPLICATION; GENETIC ASSOCIATION; GENETICS; METABOLISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE;

AGED; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STROKE;

EID: 84936741816     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105516     Document Type: Article

References (42)

1. Bonita R, Mendis S, Truelsen T, Bogousslavsky J, Toole J, et al. (2004) The global stroke initiative. Lancet Neurol 3: 391-393. (Pubitemid 38789131)
2. National 8.5 CVD collaborative Group (1998) Community comprehensive preventive study on cardial and cerebral vascular diseases. Chin J Prevent Med 32 (suppl): 3-4.
3. Shi FL, Hart RG, Sherman DG, Tegeler CH (1989) Stroke in the People's republic of China. Stroke 20: 1581-85. (Pubitemid 19278150)
4. Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, et al. (2007) Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol 6: 456-464. (Pubitemid 46551849)
5. Zhang LF, Yang J, Hong Z, Yuan GG, Zhou BF, et al. (2003) Proportion of different subtypes of stroke in China. Stroke 34: 2091-2096. (Pubitemid 37099817)
6. Sun H, Zou X, Liu L (2013) Epidemiological Factors of Stroke: A Survey of the Current Status in China. J Stroke 15(2): 109-114.
7. Yang QD, Niu Q, Zhou YH, Liu YH, Xu HW, et al. (2004) Incidence of cerebral hemorrhage in the Changsha community. A prospective study from 1986 to 2000. Cerebrovasc. Dis 17(4): 303-13. (Pubitemid 38621544)
8. He J, Klag MJ, Wu Z, Whelton PK (1995) Stroke in the People's Republic of China, II: meta-analysis of hypertension and risk of stroke. Stroke 26(12): 2228-32.
9. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, et al. (2010) INTERSTROKE investigators: Risk Factors for Ischaemic and Intracerebral Haemorrhagic Stroke in 22 Countries (the INTERSTROKE study): a case control study. The Lancet 376(9735): 112-23.
10. Dichgans M (2007) Genetics of ischaemic stroke. Lancet Neurol 6(2): 149-61.
11. Kubo M, Hata J, Ninomiya T, Matsuda K, Yonemoto K, et al. (2007) A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat Genet 39: 212-217. (Pubitemid 46184352)
12. Hata J, Matsuda K, Ninomiya T, Yonemoto K, Matsushita T, et al. (2007) Functional SNP in a Sp1-binding site of AGTRL1 gene is associated with susceptibility to brain infarction. Hum Mol Genet 6: 630-9. (Pubitemid 46585664)
13. Kohara K, Fujisawa M, Ando F, Tabara Y, Niino N, et al. (2003) MTHFR gene Polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: The NILS-LSA Study. Stroke 34: 1130-5. (Pubitemid 36547502)
14. Matsushita T, Ashikawa K, Yonemoto K, Hirakawa Y, Hata J, et al. (2010) Functional SNP of ARHGEF10 confers risk of atherothrombotic stroke. Hum Mol Genet 19: 1137-46.
15. George Peck, Liam Smeeth, John Whittaker, Juan Pablo Casas, Aroon Hingorani, et al. (2008) The Genetics of Primary Haemorrhagic Stroke, Subarachnoid Haemorrhage and Ruptured Intracranial Aneurysms in Adults. PLoS ONE 3(11): e3691.
16. Somarajan BI, Kalita J, Mittal B, Misra UK (2011) Evaluation of MTHFR C677T polymorphism in ischemic and cerebral hemorrhage patients. A case - control study in a Northern Indian population.J Neurol Sci 304: 67-70.
17. Wang X, Cheng S, Brophy VH, Erlich HA, Mannhalter C, et al. (2009) A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Stroke 40: 683-695.
18. Cheng S, Grow MA, Pallaud C, Klitz W, Erlich HA, et al. (1999) A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 9: 936-949. (Pubitemid 29525202)
19. Barcellos LF, Begovich AB, Reynolds RL, Caillier SJ, Brassat D, et al. (2004) Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Ann Neuro l55: 793-800. (Pubitemid 38702574)
20. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57: 289-300.
21. Smith NL, Hindorff LA, Heckbert SR, Lemaitre RN, Marciante KD, et al. (2007) Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA 297: 489-98. (Pubitemid 46220804)
22. Speranza Rubattu, Paul Ridker, Meir J. Stampfer, Massimo Volpe, Charles H. Hennekens et al. (1999) The Gene Encoding Atrial Natriuretic Peptide and the Risk of Human Stroke. Circulation 100: 1722-1726.
23. Rubattu S, Stanzione R, Di Angelantonio E, Zanda B, Evangelista A, et al. (2004) Atrial Natriuretic Peptide Gene Polymorphisms and Risk of Ischemic Stroke in Humans. Stroke 35(4): 814-8. (Pubitemid 38419783)
24. Gretarsdottir S, Thorleifsson G, Reynisdottir ST, Manolescu A, Jonsdottir S, et al. (2003) The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 35: 131-138. (Pubitemid 37187631)
25. Ackermann U (1986) Structure and function of atrial natriuretic peptides. Clin Chem 32(2): 241-247.
26. John SW, Krege JH, Oliver PM (1995) Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267(5198): 679-681.
27. Hodgson-Zingman DM, Karst ML, Zingman LV, Heublein DM, Darbar D, et al. (2008) Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med 359: 158-65. (Pubitemid 351962039)
28. Needleman P, Greenwald JE (1986) Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure homeostasis. N Engl J Med 314: 828-834. (Pubitemid 16138683)
29. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML (1990) Diverse biological actions of atrial natriuretic peptide. Physiol Rev 70: 665-699. (Pubitemid 20196047)
30. Atlas S, Maack T (1992) Atrial natriuretic factor. In: EE. Windhager (ed) Handbook of Physiology:Renal Physiology. New York, NY: Oxford University Press pp 1577-1673.
31. Frosst P, Blom HJ, Milos R (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113.
32. Jakubowski H, Zhang L, Bardeguez A, Aviv A (2000) Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis. Circ Res 87: 45-51. (Pubitemid 30456934)
33. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA (1997) Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 95: 1119-1121. (Pubitemid 27097819)
34. Stoll G, Bendszus M (2006) Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 37: 1923-1932. (Pubitemid 44297753)
35. Mazighi M, Labreuche J, Gongora-Rivera F, Duyckaerts C, Hauw JJ, et al. (2008) Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke. Stroke 39: 1142-1147. (Pubitemid 351440682)
36. Sazci A, Ergul E, Tuncer N, Akpinar G, Kara I (2006) Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and cerebral hemorrhage: dual effect of MTHFR polymorphisms C677T and A1298C. Brain Res Bull 71: 45-50. (Pubitemid 44750419)
37. Li Z, Sun L, Zhang H, Liao Y, Wang D (2003) Elevated Plasma Homocysteine Was Associated With Hemorrhagic and Ischemic Stroke,but Methylenetetrahydrofolate Reductase Gene C677T Polymorphism Was a Risk Factor for Thrombotic Stroke: A Multicenter Case-Control Study in China.Stroke 34(9): 2085-90. (Pubitemid 37099816)
38. Cronin S, Furie KL, Kelly PJ (2005) Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke 36: 1581-7. (Pubitemid 40967536)
39. Franco RF, Araujo AG, Guerriero JF, Elion J, Zago MA (1998) Analysis of the 677 C>T mutation of the methylenetetrahydrofolate redustase gene in different ethnic groups. Thromb Haemost 79: 119-21. (Pubitemid 28037069)
40. Kannel Wb, Wolf PA, Verter J, mcMara P (2008) Framingham Study insights on the hazards of elevated blood pressure. JAMA 300: 2545-7.
41. David Conen, Robert J. . Glynn, Julie E. . Buring, Paul M . Ridker and Robert Y.L. . Zee (2007) Natriuretic Peptide Precursor A Gene Polymorphisms and Risk of Blood Pressure Progression and Incident Hypertension. Hypertension 50: 1114-1119.
42. Qian X, Lu Z, Tan M, Liu H, Lu D (2007) A meta-analysis of association between C677T polymorphism in the methylenetetrahydrofolate reductase gene and hypertension. Eur J Hum Genet 15: 1239-1245. (Pubitemid 350143180)